Related Experiment Video
Updated: Oct 12, 2025
06:01
Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
Published on: July 26, 2024
777
Digital health for functional gastrointestinal disorders
Mythili P Pathipati1, Eric D Shah2, Braden Kuo1
1Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Neurogastroenterology and Motility
|November 19, 2021
Summary
Digital health tools offer new ways to manage functional gastrointestinal disorders (FGIDs). These technologies improve patient monitoring and support, addressing challenges in current gastroenterology care.
Area of Science:
- Gastroenterology
- Digital Health
- Patient Care Technology
Background:
- Functional gastrointestinal disorders (FGIDs) present significant treatment challenges for gastroenterology practices.
- Current care models struggle with the intensive monitoring, communication, and external stressor management required for FGID patients.
- Digital health applications are emerging as valuable tools to enhance care for FGID patients.
Purpose of the Study:
- To review the current applications of digital health in managing functional gastrointestinal disorders.
- To provide examples of relevant digital health technologies and organizations in this field.
- To identify limitations in existing treatment strategies and propose solutions through digital health integration.
Main Methods:
- Literature review of digital health applications for FGIDs.
- Analysis of current technologies and organizational roles.
- Evaluation of treatment shortcomings and potential digital solutions.
Main Results:
- Digital health tools facilitate improved symptom tracking and physiologic monitoring for FGID patients.
- These technologies enable direct provision of care and enhanced patient support.
- Examples of current digital health interventions and their impact are presented.
Conclusions:
- Digital health applications show promise in overcoming current treatment limitations for functional gastrointestinal disorders.
- Integration of these tools can lead to more effective and accessible care for FGID patients.
- Further development and adoption of digital health are recommended for improved gastroenterology practice.
Related Concept Videos
01:29Assessment of the Gastrointestinal System II: Health Perception Pattern
186
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
186
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
451
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
451
01:17Assessment of the Gastrointestinal System I: Subjective Data
328
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
328
01:20Gastrointestinal Motility Disorders
659
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
659
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
450
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
450
01:17Drugs for Treatment of Diarrhea-Predominant IBS
353
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
353